Logo
SubscribeSign In
LeaderPortfolio
Billionaire Profile
Wilhelm Beier & family
Global Rank
#1391

Image: Unknown authorUnknown author | Public domain | via Wikimedia Commons

Wilhelm Beier & family

CEO, Pharmaceuticals
GERMANY
Real-Time Net Worth
$2.98B
Estimated based on Pharmaceuticals stock value as of March 6, 2026
-0.31% (24h)
Age
69
Source
Pharmaceuticals
Industry
Healthcare
Citizenship
GERMANY

Biography

Wilhelm Beier, born April 21, 1956, is a prominent figure in the pharmaceutical industry, best known as the founder of Dermapharm, a leading German pharmaceutical company. With an estimated net worth of $3 billion, Beier's career has been marked by innovation, dedication, and strategic thinking. Dermapharm, established in 1991, specializes in manufacturing and marketing patent-free pharmaceuticals, and under Beier's leadership, has expanded significantly, including the production of the COVID-19 vaccine Comirnaty. Beier's successful ventures have solidified his position as a major player in the healthcare sector.

Fact Checked
Verified by Editorial Team
Live Data
Updated 3/6/2026

Wealth Over Time

In-Depth Profile

Early Life

Wilhelm Beier was born on April 21, 1956. He grew up in Bad Münstereifel and started his career as a sales representative at Ratiopharm. In the late 1980s, he moved to Centrafarm (later known as “Dorsch”).

Rise to Success

Beier founded Dermapharm in 1991. The company specializes in manufacturing and marketing patent-free pharmaceuticals. In 2018, Beier took Dermapharm public. In October 2020, Dermapharm began producing the COVID-19 vaccine Comirnaty on behalf of BioNTech. Dermapharm's annual sales exceed $700 million, and the company has a workforce of over 1,800.

Key Business Strategies

Dermapharm focuses on manufacturing generic drugs. The company also has a significant portion of its revenue coming from "parallel trade," which involves exploiting price differences for drugs between countries. Also, Dermapharm is expanding into the medical marijuana business.

Philanthropy

Specific philanthropy amounts are not available in the provided search results, though STADA Arzneimittel AG is involved in charity projects.

Career Milestones

1991

Founded Dermapharm

Established Dermapharm, a pharmaceutical company specializing in patent-free drugs.

2018

Dermapharm IPO

Took Dermapharm public, raising approximately €307 million.

2020

Comirnaty Production

Began producing the COVID-19 vaccine Comirnaty for BioNTech.

Compare Wilhelm Beier & family

Net Worth Face-off
Wilhelm Beier & family vs Elon Musk
Compare Wealth →
Net Worth Face-off
Wilhelm Beier & family vs Jeff Bezos
Compare Wealth →
Net Worth Face-off
Wilhelm Beier & family vs Mark Zuckerberg
Compare Wealth →